India's Pharma Crisis: Toxic DEG in Cough Syrup Kills Nine Children
India's health ministry has discovered alarming levels of diethylene glycol (DEG), a toxic industrial solvent, in Coldrif cough syrup produced by Sresan Pharma in Tamil Nadu. This revelation follows the tragic deaths of at least nine children, prompting authorities in multiple states to ban the sale of the syrup.
DEG, which should not be present in cough syrup, is known for its severe toxicity. The incident has sparked renewed scrutiny of India's pharmaceutical industry, which is the world's third-largest by volume, producing affordable generic drugs. Following the discovery, authorities in Madhya Pradesh, Tamil Nadu, and Kerala have prohibited the sale of Coldrif cough syrup. The company behind the dangerous product, Sresan Pharmaceuticals, has faced a ban on its other products in Madhya Pradesh as well. This incident echoes previous warnings from the World Health Organization (WHO) linking Indian-made cough syrups to child deaths in Gambia, Uzbekistan, and Iraq. In response, the government and health authorities are investigating the incident to enforce stricter safety compliance and prevent such tragedies in the future.
The presence of DEG in Coldrif cough syrup has led to a public health crisis, with at least nine children losing their lives. The incident has raised concerns about the safety of India's pharmaceutical industry and prompted authorities to take swift action. As investigations continue, the focus remains on ensuring the safety and quality of medicines produced in the country.
Read also:
- Overweight women undergoing IVF have a 47% higher chance of conceiving naturally post-weight loss
- Bonsai Trees from Evergreen Species: Exploring Growth Characteristics & Distinct Qualities
- What temperatures may make walking your canine companion uncomfortable?
- Title: Information About Beovu: Potency, Form, Usage, and Additional Details
